Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 4, 2005, Pages 885-891

  Stepanov, Irina ^a   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; GLUCURONIDE; N NITROSOANABASINE; NITROSAMINE; NITROSOANATABINE; NITROSONORNICOTINE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HUMAN; HYDROLYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOKELESS TOBACCO; SMOKING; SOLID PHASE EXTRACTION; STANDARD; TANDEM MASS SPECTROMETRY; URINALYSIS;

ANIMALS; CARCINOGENS; CHROMATOGRAPHY, GAS; COTININE; CREATININE; GLUCURONIDES; HUMANS; NITROSAMINES; SMOKING; TOBACCO, SMOKELESS;

EID: 16444374852     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0753     Document Type: Article

References (34)

1. IARC. Tobacco smoking. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Lyon (France): IARC; 1986. p. 37-375.
2. IARC. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon (France): IARC; 2004.
3. Hoffmann D, Adams JD, Lisk D, et al. Toxic and carcinogenic agents in dry and moist snuff. J Natl Cancer Inst 1987;79:1281-6.
4. Hoffmann D, Hoffmann I, El Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 2001;14:767-90.
5. Swauger JE, Steichen TJ, Murphy PA, et al. An analysis of the mainstream smoke chemistry of samples of the U.S. cigarette market acquired between 1995 and 2000. Regul Toxicol Pharmacol 2002;35:142-56.
6. Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 1988;9:875-84.
7. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
8. Spiegelhalder B, Bartsch H. Tobacco-specific nitrosamines. Eur J Cancer Prev 1996;5:33-8.
9. Hecht SS, Hoffmann D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv 1989;8:273-94.
10. Hecht SS. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
11. IARC. Tobacco habits other than smoking: betel-quid and areca-nut chewing and some related nitrosamines. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Lyon (France): IARC; 1985. p. 31-202.
12. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002;23:907-22.
13. Upadhyaya P, Zimmerman CL, Hecht SS. Metabolism and pharmacokinetics of N′-nitrosonornicotine in the patas monkey. Drug Metab Dispos 2002;30:1115-22.
14. Byrd GD, Chang KM, Greene JM, et al. Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3′-hydroxycotinine in smokers. Drug Metab Dispos 1992;20:192-7.
15. Benowitz NL, Jacob P, Fong I, et al. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994;268:296-303.
16. Hecht SS, Carmella SG, Murphy SE. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol Biomarkers Prev 1999;8:907-13.
17. Carmella SG, Le Ka KA, Upadhyaya P, et al. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol (NNAL) in human urine. Chem Res Toxicol 2002;15:545-50.
18. Amin S, Desai D, Hecht SS, et al. Synthesis of tobacco-specific N-nitrosamines and their metabolites and results of related bioassays. Crit Rev Toxicol 1996;26:139-47.
19. Carmella SG, McIntee EJ, Chen M, et al. Enantiomeric composition of N′-nitrosonornicotine and N′-nitrosoanatabine in tobacco. Carcinogenesis 2000;21:839-43.
20. 2 in humans. Biol Mass Spectrom 1991;20:247-52.
21. Curvall M, Elwin CE, Kazemi-Vala E, et al. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol 1990;38:281-7.
22. Hecht SS, Carmella SG, Chen M, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 1999;59:590-6.
23. Carmella SG, Han S, Fristad A, et al. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol Biomarkers Prev 2003;12:1257-61.
24. Hecht SS, Hatsukami DK, Bonilla LE, et al. Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl) butanoic acid in human urine: a substantial pathway of nicotine metabolism. Chem Res Toxicol 1999;12:172-9.
25. Hoffmann D, Djordjevic MV, Fan J, et al. Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst 1995;87:1862-9.
26. Carmella S, Borukhova A, Desai D, et al. Evidence for endogenous formation of tobacco-specific nitrosamines from nicotine and other tobacco alkaloids in rats. Carcinogenesis 1997;18:587-92.
27. Schmeltz I, Hoffmann D. Nitrogen containing compounds in tobacco and tobacco smoke. Chem Rev 1977;77:295-311.
28. Ren Q, Murphy SE, Zheng Z, et al. O-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9. Drug Metab Dispos 2000;28:1352-60.
29. Wiener D, Doerge DR, Fang JL, et al. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4. Drug Metab Dispos 2004;32:72-9.
30. Kuehl GE, Murphy SE. N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases. Drug Metab Dispos 2003;31:1361-8.
31. Benowitz NL, Jacob P III. Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism. Clin Pharmacol Ther 2000;67:653-9.
32. Zevin S, Benowitz NL. Drug interactions with tobacco smoking: an update. Clin Pharmacokinet 1999;36:425-38.
33. Miners JO, MacKenzie PI. Drug glucuronidation in humans. Pharmacol Ther 1991;51:347-69.
34. Hecht SS, Trushin N, Reid-Quinn CA, et al. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis 1993;14:229-36.